Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.
A limiting antigen avidity enzyme immunoassay (HIV-1 LAg-Avidity assay) was recently developed for cross-sectional HIV incidence estimation. We evaluated the performance of the LAg-Avidity assay alone and in multi-assay algorithms (MAAs) that included other biomarkers.Performance of testing algorith...
Main Authors: | Jacob Konikoff, Ron Brookmeyer, Andrew F Longosz, Matthew M Cousins, Connie Celum, Susan P Buchbinder, George R Seage, Gregory D Kirk, Richard D Moore, Shruti H Mehta, Joseph B Margolick, Joelle Brown, Kenneth H Mayer, Beryl A Koblin, Jessica E Justman, Sally L Hodder, Thomas C Quinn, Susan H Eshleman, Oliver Laeyendecker |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3873916?pdf=render |
Similar Items
-
A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.
by: Matthew M Cousins, et al.
Published: (2014-01-01) -
Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.
by: Oliver Laeyendecker, et al.
Published: (2010-10-01) -
Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection.
by: Matthew M Cousins, et al.
Published: (2011-01-01) -
Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.
by: Sarah K Wendel, et al.
Published: (2013-01-01) -
Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
by: Diane Wallace Taylor, et al.
Published: (2020-05-01)